BridgeMD
New treatment option for SCHIZOPHRENIA 1 (Disorder)
Official title The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia
ClinicalTrials.gov ID: NCT07144592
What this study is testing
- What it's testing
- The aim of this study is to evaluate the effects of a solution-focused approach-based individual intervention on psychosocial adjustment and treatment adherence in individuals diagnosed with schizophrenia. The study will be conducted as a randomized controlled trial including 60 clinically stable individuals diagnosed with schizophrenia according to DSM-5 criteria and registered at a Community Mental Health Center affiliated with a university hospital.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Having been diagnosed with schizophrenia according to DSM-5 diagnostic criteria,
- Being between 18 and 65 years of age,
- Being literate and verbally communicative,
- Being clinically stable (not exhibiting symptoms of acute psychosis),
- Being registered with a Community Mental Health Center (CMHC) and receiving regular services,
You likely can't join if
- those who do not meet the inclusion criteria
See the full eligibility criteria
- Having been diagnosed with schizophrenia according to DSM-5 diagnostic criteria,
- Being between 18 and 65 years of age,
- Being literate and verbally communicative,
- Being clinically stable (not exhibiting symptoms of acute psychosis),
- Being registered with a Community Mental Health Center (CMHC) and receiving regular services,
- Being cognitively competent enough to participate in individual interviews during the research process,
- Being an individual currently receiving psychiatric treatment and taking medication,
- Agreeing to participate voluntarily in the study and signing a written informed consent form.
- those who do not meet the inclusion criteria
The study team makes the final eligibility decision.
Where it's taking place
- Muş, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Muş, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.